News & Announcements
Fox Chase Cancer Center Leader Tours China with Mayor Nutter
Fox Chase Cancer Center will be sharing its oncologic expertise with peers at Tianjin Medical University Cancer Institute and Hospital in Tianjin, China, thanks to an agreement signed in the Chinese port city on December 3.
Kurt Schwinghammer, PhD, Vice President of Research & Development Alliances at Fox Chase Cancer Center and head of Fox Chase International, was a member of a contingent of Philadelphia leaders in medicine, education, law, and the arts traveling with Mayor Michael Nutter to Tianjin — which, since 1980, has been a Sister City of Philadelphia.
Mayor Nutter's trip focused on encouraging international investment in Philadelphia and strengthening relationships between important local institutions and their counterparts in China. The trip also took the group about 70 miles northwest of Tianjin to Beijing, where Mayor Nutter, current president of the U.S. Conference of Mayors, spoke on urban sustainability.
According to Dr. Schwinghammer, urban sustainability - the concept central to the Mayor's activities in China - is linked to Fox Chase's mission. "Cancer is now the leading cause of death in China, with lung cancer being at the top of the list. It is likely that there is a relationship between long-term exposure to air pollution and cancer," he explained.
The partnership forged in Tianjin is not the first of its kind for Fox Chase. Through Fox Chase International, the Center seeks to align the skills and resources of cancer research, diagnosis and treatment available at Fox Chase with the extraordinary growth of cancer treatment and diagnostic requirements in China and other nations. So far, Fox Chase has formed relationships with institutions in six cities in China and India.
Date Published: Thursday, December 27, 2012
back | view all news
Temple University Hospital Offering New Treatment for Chronic Obstructive Pulmonary Disease
Temple University Hospital is one of only three hospitals nationwide participating in a Phase II clinical trial testing whether or not an investigational oral tablet therapy will suppress inflammation and ease breathing for patients suffering from moderate to severe Chronic Obstructive Pulmonary Disease.
read more »
Medical Education Risks Becoming Two-Tiered Unless Strong Research Focus is Preserved, Argue Philadelphia Medical Leaders
In a a position paper published by Science Translational Medicine and co-authored by Arthur Feldman, MD, PhD, Executive Dean of Temple University School of Medicine and Chief Academic Officer for the Temple University Health System, Arthur H. Rubenstein, MBBCh, Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, the authors argue that the U.S. is headed for a two-tiered system, one that exposes students to research and physician-scientists, and another that trains students with exclusively practitioners as role models.
read more »
61 Temple Physicians Named "Top Doctors" by Philadelphia Magazine
Sixty-one Temple physicians have been named to Philadelphia magazine's "Top Doctors" list for 2015
read more »